BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27539625)

  • 21. Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.
    Chang YS; Fang HY; Hung YC; Ke TW; Chang CM; Liu TY; Chen YC; Chao DS; Huang HY; Chang JG
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2167-2175. PubMed ID: 30203147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
    Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
    Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case.
    Appierto V; Di Cosimo S; Reduzzi C; Pala V; Cappelletti V; Daidone MG
    Semin Cancer Biol; 2017 Jun; 44():106-116. PubMed ID: 28442298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias.
    Gerber B; Manzoni M; Spina V; Bruscaggin A; Lionetti M; Fabris S; Barbieri M; Ciceri G; Pompa A; Forestieri G; Lerch E; Servida P; Bertoni F; Zucca E; Ghielmini M; Cortelezzi A; Cavalli F; Stussi G; Baldini L; Rossi D; Neri A
    Haematologica; 2018 Jun; 103(6):e245-e248. PubMed ID: 29472358
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.
    Zill OA; Greene C; Sebisanovic D; Siew LM; Leng J; Vu M; Hendifar AE; Wang Z; Atreya CE; Kelley RK; Van Loon K; Ko AH; Tempero MA; Bivona TG; Munster PN; Talasaz A; Collisson EA
    Cancer Discov; 2015 Oct; 5(10):1040-8. PubMed ID: 26109333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Plasma Tumor DNA.
    Parsons HA; Beaver JA; Park BH
    Adv Exp Med Biol; 2016; 882():259-76. PubMed ID: 26987539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
    Nakauchi C; Kagara N; Shimazu K; Shimomura A; Naoi Y; Shimoda M; Kim SJ; Noguchi S
    Clin Breast Cancer; 2016 Oct; 16(5):418-423. PubMed ID: 27265061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study.
    Ball MW; Gorin MA; Guner G; Pierorazio PM; Netto G; Paller CJ; Hammers HJ; Diaz LA; Allaf ME
    Clin Genitourin Cancer; 2016 Oct; 14(5):e515-e520. PubMed ID: 27150639
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel diagnostic biomarker for patients with Non-Hodgkin's Lymphoma by IgH gene rearrangement.
    Bo J; Sun L; Wang W; Ma C; Li H; Zhao Y
    J Cancer Res Ther; 2016; 12(2):903-8. PubMed ID: 27461672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.
    Bins S; Cirkel GA; Gadellaa-Van Hooijdonk CG; Weeber F; Numan IJ; Bruggink AH; van Diest PJ; Willems SM; Veldhuis WB; van den Heuvel MM; de Knegt RJ; Koudijs MJ; van Werkhoven E; Mathijssen RH; Cuppen E; Sleijfer S; Schellens JH; Voest EE; Langenberg MH; de Jonge MJ; Steeghs N; Lolkema MP
    Oncologist; 2017 Jan; 22(1):33-40. PubMed ID: 27662884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
    Fontanilles M; Marguet F; Bohers É; Viailly PJ; Dubois S; Bertrand P; Camus V; Mareschal S; Ruminy P; Maingonnat C; Lepretre S; Veresezan EL; Derrey S; Tilly H; Picquenot JM; Laquerrière A; Jardin F
    Oncotarget; 2017 Jul; 8(29):48157-48168. PubMed ID: 28636991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid Biopsies for Assessing Metastatic Melanoma Progression.
    Huynh K; Hoon DS
    Crit Rev Oncog; 2016; 21(1-2):141-54. PubMed ID: 27481010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the Precision Medicine Toolkit With Circulating Tumor DNA.
    Roschewski M; Wilson WH
    JCO Oncol Pract; 2020 Sep; 16(9):569-570. PubMed ID: 32910880
    [No Abstract]   [Full Text] [Related]  

  • 36. Monitoring gastric cancer progression with circulating tumour DNA.
    Hamakawa T; Kukita Y; Kurokawa Y; Miyazaki Y; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Taniguchi K; Takiguchi S; Mori M; Doki Y; Kato K
    Br J Cancer; 2015 Jan; 112(2):352-6. PubMed ID: 25490524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker.
    Pietrasz D; Pécuchet N; Garlan F; Didelot A; Dubreuil O; Doat S; Imbert-Bismut F; Karoui M; Vaillant JC; Taly V; Laurent-Puig P; Bachet JB
    Clin Cancer Res; 2017 Jan; 23(1):116-123. PubMed ID: 27993964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor DNA: new horizons for improving cancer treatment.
    Lianos GD; Mangano A; Cho WC; Dionigi G; Roukos DH
    Future Oncol; 2015; 11(4):545-8. PubMed ID: 25686109
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulating tumor DNA profiling by next generation sequencing reveals heterogeneity of crizotinib resistance mechanisms in a gastric cancer patient with MET amplification.
    Du J; Wu X; Tong X; Wang X; Wei J; Yang Y; Chang Z; Mao Y; Shao YW; Liu B
    Oncotarget; 2017 Apr; 8(16):26281-26287. PubMed ID: 28460431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing.
    Schwaederle M; Chattopadhyay R; Kato S; Fanta PT; Banks KC; Choi IS; Piccioni DE; Ikeda S; Talasaz A; Lanman RB; Bazhenova L; Kurzrock R
    Cancer Res; 2017 Oct; 77(19):5419-5427. PubMed ID: 28807936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.